Health

Breast Cancer Treatment Advances

Updated 2026-09-17 00:10 UTC 1 source Positive

The NHS in England has approved the use of Enhertu, a life-extending drug for breast cancer patients. This follows its availability in Scotland since over two years.

Coverage timeline — 2 articles
BBC News
Evan Speigel says it would be "an important step forward for the industry" in an interview with the BBC.
2026-09-16 23:41 UTC
BBC News
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
2026-09-16 23:50 UTC
Share: Twitter / X LinkedIn